Guimarães, Portugal – September 08, 2017
Stemmatters, a biotechnology company providing contract manufacturing organization (CMO) services, has been granted Good Manufacturing Practice (GMP) certification for Biological Medicinal Products.
The certificate was granted by the Portuguese National Authority of Medicines and Health Products (INFARMED) that has recently inspected company’s manufacturing facilities. The certificate of GMP compliance covers the manufacture and quality control testing of human investigational medicinal products.
“The certificate of GMP compliance for our manufacturing facilities is an important milestone for Stemmatters’ CMO business unit, and a reassurance to our clients of the high standard of quality and full regulatory compliance of our manufacturing facilities. This reinforces our commitment as a third-party manufacturing partner for biological medicinal products, in particular blood derived products”, said Rui A. Sousa, Chief Executive Officer, Stemmatters.
Stemmatters is a regenerative medicine company focused in new product development and manufacturing. Stemmatters operates as a CMO business for biologics and cell-based products. Stemmatters also operates a research and development business unit focused in the development of next generation biomaterials.
For further information, please contact:
Rui A. Sousa (CEO) | firstname.lastname@example.org